5,646 Shares in Encompass Health Corporation $EHC Purchased by Precision Wealth Strategies LLC

Precision Wealth Strategies LLC purchased a new position in Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 5,646 shares of the company’s stock, valued at approximately $692,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. WPG Advisers LLC acquired a new stake in shares of Encompass Health in the first quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after purchasing an additional 367 shares during the period. Arlington Trust Co LLC raised its stake in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after buying an additional 125 shares during the last quarter. Park Place Capital Corp acquired a new position in shares of Encompass Health in the 2nd quarter valued at about $72,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by corporate insiders.

Analyst Ratings Changes

EHC has been the subject of a number of analyst reports. UBS Group boosted their price target on Encompass Health from $130.00 to $140.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Bank of America raised their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Wall Street Zen cut shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a report on Friday, June 6th. Finally, Stephens raised shares of Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 target price on the stock in a research note on Thursday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company’s stock. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and a consensus target price of $138.43.

Encompass Health Price Performance

Shares of NYSE EHC opened at $124.59 on Thursday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a fifty day moving average of $120.61 and a 200 day moving average of $115.19. The firm has a market cap of $12.55 billion, a PE ratio of 24.38, a PEG ratio of 2.22 and a beta of 0.93. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.86.

Encompass Health (NYSE:EHC) last announced its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is 13.31%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.